The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis

被引:462
作者
Singh, Gitanjali M. [1 ]
Danaei, Goodarz [2 ,3 ]
Farzadfar, Farshad [4 ,5 ]
Stevens, Gretchen A. [6 ]
Woodward, Mark [7 ,8 ]
Wormser, David [9 ]
Kaptoge, Stephen [9 ]
Whitlock, Gary [10 ]
Qiao, Qing [11 ]
Lewington, Sarah [10 ]
Di Angelantonio, Emanuele [9 ]
vander Hoorn, Stephen [12 ]
Lawes, Carlene M. M. [13 ]
Ali, Mohammed K. [14 ]
Mozaffarian, Dariush [1 ,3 ,15 ,16 ,17 ]
Ezzati, Majid [18 ]
机构
[1] Harvard Univ, Sch Med, Dept Nutr, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Global Hlth & Populat, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Univ Tehran Med Sci, Diabet Res Ctr, Tehran, Iran
[5] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran
[6] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland
[7] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia
[8] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
[9] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[10] Univ Oxford, Clin Trial Serv Unit, Oxford, England
[11] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[12] Univ Melbourne, Dept Stat, Melbourne, Vic, Australia
[13] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand
[14] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA
[15] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA
[16] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[17] Harvard Univ, Sch Med, Boston, MA USA
[18] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Environm & Hlth,Hlth Protect Agcy,MRC, London, England
来源
PLOS ONE | 2013年 / 8卷 / 07期
基金
英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; HEALTH EXAMINATION SURVEYS; BODY-MASS INDEX; BLOOD-PRESSURE; LOWERING TREATMENT; GLUCOSE; METAANALYSIS; MORTALITY; EVENTS;
D O I
10.1371/journal.pone.0065174
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. Methods: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. Results: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. Conclusion: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
引用
收藏
页数:10
相关论文
共 61 条
  • [1] The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
    不详
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (12) : 839 - 869
  • [2] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [3] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [4] Balkau B, 2000, DIABETES METAB, V26, P282
  • [5] Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
    Boussageon, Remy
    Bejan-Angoulvant, Theodora
    Saadatian-Elahi, Mitra
    Lafont, Sandrine
    Bergeonneau, Claire
    Kassai, Behrouz
    Erpeldinger, Sylvie
    Wright, James M.
    Gueyffier, Francois
    Cornu, Catherine
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [6] Bariatric surgery: A systematic review and meta-analysis
    Buchwald, H
    Avidor, Y
    Braunwald, E
    Jensen, MD
    Pories, W
    Fahrbach, K
    Schoelles, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14): : 1724 - 1737
  • [7] SERUM-CHOLESTEROL CONCENTRATION AND CORONARY HEART-DISEASE IN POPULATION WITH LOW CHOLESTEROL CONCENTRATIONS
    CHEN, ZM
    PETO, R
    COLLINS, R
    MACMAHON, S
    LU, JR
    LI, WX
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6797) : 276 - 282
  • [8] Cholesterol Treatment Trialists' (CTT) Collaborators, 2012, LANCET
  • [9] Collins R, 2004, LANCET, V363, P757
  • [10] Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
    Danaei, Goodarz
    Lawes, Carlene M. M.
    Hoorn, Stephen Vander
    Murray, Christopher J. L.
    Ezzati, Majid
    [J]. LANCET, 2006, 368 (9548) : 1651 - 1659